We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reneuron Group Plc | LSE:RENE | London | Ordinary Share | GB00BF5G6K95 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.05 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 530k | -5.41M | -0.0946 | -0.32 | 1.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/10/2019 08:59 | but these results are in line with high end expectations. Those with the better eyesight where expected to show the most gains | eggy6198 | |
02/10/2019 08:58 | The other thing that concerns me is that I was thinking that with a good rns behind us the share price would blast past £3 but we will now have to wait for the next checkpoint so my thinking is that a drift back to £2.00 is on the cards unless the conference brings in another partner. Just my thoughts and still positive. | king1pin2 | |
02/10/2019 08:44 | Yes thanks but I cant be the only person to read the rns as slightly negitive. It just seemed that they were not 100% happy with the results but wanted to put a positive spin on the rns. | king1pin2 | |
02/10/2019 08:43 | Buy on rumour and sell on news. At least until it settles down. | red army | |
02/10/2019 08:43 | "....two patients experiencing surgical procedure-related loss of vision" More clarification required. | rotors | |
02/10/2019 08:42 | I believe there is only one patient in the post 9 months category (n=1) whereas there are 4 (different) patients in the 6 month category. Looking back to the April announcement there was only one patient in the 120 day category so five months later that individual would be in the 9 month category. That's my interpretation at least, happy to be corrected. All the best. | makw61 | |
02/10/2019 08:40 | Marwalker- There has been no fall in vision acuity improvement in any patient. The effect you noticed is due to patients enrolled into the later trial that are not counted in months 6 and 9 as they have not been on the trial long enough. Data used for months one to three includes six patients. Data used for month six includes three patients. Data used for month nine is just one patient. Therefore, the visual acuity improvement of the single patient that has been in the trial for 9 months is shown in it's singular perfection only in the 9 month data, the contribution it makes to the average figures in previous months is overshadowed by the even greater improvements from the more recent recruits that are included in those averages. Hope this makes sense! :) | masingi | |
02/10/2019 08:35 | Hmm I was thinking that with the rns not in the fantastic category woodford may need to sell some of his shares and bank some recent gains . Want to be positive but got that feeling when reading the rns. | king1pin2 | |
02/10/2019 08:28 | Not forgetting Woodford. He has to tidy up & it means some hope for his unfortunate investors. I forget how many he has still, but it's going to be a tug of war between him & the positive direction of the shares. Patience will win (I'm NOT selling). Woody got that one right & his stake might interest an II or other pharma company? | napoleon 14th | |
02/10/2019 08:21 | But does not the fall in vision acuity improvement from 28.7 to 12 in the 6 to 9 month period cause concern ? Comment appreciated. | marwalker | |
02/10/2019 08:09 | Large sell being worked ? | ttjohns | |
02/10/2019 08:09 | Oh well. It was good while it lasted. | investordave | |
02/10/2019 08:02 | MMs mopping up limit orders on the open. | bantam175 | |
02/10/2019 07:59 | They are indeed. | investordave | |
02/10/2019 07:56 | Simply astonishing results... | bonzo | |
02/10/2019 07:39 | Where o where is Mr Ken Chung? | volsung | |
02/10/2019 07:36 | Making money and changing lives. It's the perfect combination. | mirabeau | |
02/10/2019 07:36 | There are literally zero options for patients with RP. This data is highly encouraging. These shares should be worth at least 3 times current.... | rrb | |
02/10/2019 07:34 | Shorters on toast. A lovely sight. | investordave | |
02/10/2019 07:33 | Obviously leaked somewhere, but as I'm long since 85p I don't give a damn! Just roast a few more shorters...... | napoleon 14th | |
02/10/2019 07:32 | Today's opening is going to be fun. Hold on chaps. | investordave | |
02/10/2019 07:31 | More momentum for the breakout | audigger | |
02/10/2019 07:28 | Agreed, seems a different style RNs to previous ones | martinfrench | |
02/10/2019 07:24 | Looks like a good result but not sure of the wording used. | king1pin2 | |
02/10/2019 07:18 | Anyone short will now have that awful sick feeling, well done LTH's | peteark |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions